Bismuth-Based Triple Therapy with Bismuth Subcitrate, Metronidazole and Tetracycline in the Eradication of Helicobacter pylori: A Randomised, Placebo Controlled, Double-Blind Study
OBJECTIVE: To determine the rate of Helicobacter pylori eradication following bismuth-based triple therapy with colloidal bismuth subcitrate, tetracycline hydrochloride and metronidazole.
Saved in:
Main Authors: | Sander Veldhuyzen van Zanten, Alain Farley, Norman Marcon, Raymond Lahaie, André Archambault, Richard Hunt, Robert Bailey, David Owen, Jean Spénard, Alan Stiglick, Nick Aimola, Patrick Colin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2000-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2000/690307 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Randomized Trial Comparing Seven-Day Ranitidine Bismuth Citrate and Clarithromycin Dual Therapy to Seven-Day Omeprazole, Clarithromycin and Amoxicillin Triple Therapy for the Eradication of Helicobacter pylori
by: Sander Veldhuyzen van Zanten, et al.
Published: (2003-01-01) -
The role of bismuth drugs in elevation of Helicobacter pylori infection eradication efficacy
by: A. A. Sheptulin
Published: (2018-08-01) -
Ranitidine bismuth citrate: A review
by: N Chiba, et al.
Published: (2001-01-01) -
Modern potential of bismuth in gastroenterology
by: A. A. Sheptulin, et al.
Published: (2010-06-01) -
Mechanochemical synthesis of bismuth ferrite
by: Marinković-Stanojevića Z., et al.
Published: (2013-01-01)